<DOC>
	<DOC>NCT00866229</DOC>
	<brief_summary>Early statin therapy in SLE patients that have high cholesterol level and other atherosclerosis risk should reduce atherosclerosis and coronary artery events in later course of disease. By the way, statin is used in restricted groups of rheumatologists due to awareness of side effects; myositis and hepatitis, that are frequently found in SLE patients more so than other groups of atherosclerosis patients and reporting data of autoimmune diseases that occur after statin use.</brief_summary>
	<brief_title>Efficacy and Adverse Effect of Simvastatin Compare to Rosuvastatin in Systemic Lupus Erythematosus (SLE) Patients With Corticosteroid Therapy and High Low-Density Lipoprotein (LDL) Cholesterol Level</brief_title>
	<detailed_description />
	<mesh_term>Lupus Erythematosus, Systemic</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>SLE patients that on prednisolone more than 30 mg/day Normal liver faction: AST and ALT &lt; 80 mg/dl Normal muscle enzyme : CPK &lt; 100 U/L LDL cholesterol level &gt; 100 mg/dl Patients that was treated with pulse methylprednisolone or corticosteroid equivalent to prednisolone &gt; 1mg/kg/day at screening. Statin allergy On statin treatment before screening On cyclosporine, antifugal (azole group), antibiotics (macrolide group), rifampicin, warfarin, phenytoin Pregnancy Abnormal liver function: AST or ALT &gt; 80 mg/dl Abnormal muscle enzyme : CPK &gt; 300 U/L</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2009</verification_date>
</DOC>